IL-6, Mouse, mAb MP5-20F3
Catalog #: HM1004-01
Quantity: 100 µg
The antibody neutralizes mouse interleukin 6 (IL-6). It does not cross-react with LPS (the component of the bacterial cell wall which is considered responsible for the toxicity of gram-negative bacteria) and TNFalpha nor does it bind to either human or rat IL-6. The antibody inhibits IL-6 induced proliferation of the B9 assay. IL-6 is a pluripotent 20-22 kDa cytokine which plays a role in the pathophysiology of severe infection and regulates the immune response, acute phase reaction and haematopoiesis. IL-6 plays a critical role in B-cell differentiation to plasma cells and is a potent growth factor for plasmacytoma and myeloma. Continuous IL-6 gene expression makes an essential contribution to a multistep oncogenesis of plasma cell neoplasia. IL-6 is a very useful culture supplement for the generation of a high number of antibody-producing hybridomas.
|Product type||Monoclonal antibodies|
|Formulation||1 ml (100 μg/ml) 0.2 μm filtered antibody solution in PBS containing 0.1% bovine serum albumin.|
|Storage and stability||Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.|
|Precautions||For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and Federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result with the use of or derivation of this product.|
|Disease||Autoimmunity, Tumor immunology|
Application:FS, IA, IP
Application Notes:The antibody can be used for in vitro and in vivo inhibition of activity of IL-6. Furthermore the antibody is useful for immunochemical investigations of mouse IL-6 in structural studies and for quantitative/qualitative immunochemical detection methods. This antibody may be used as a coating antibody in immuno assay procedures.
Use:For neutralisation of biological activity dilutions have to be made according to the amount of IL-6 to be inactivated.
1. Takatsuki, F et al; Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 1988, 141: 3072 2. McKenzie, D et al; Alloantigen presentation by B cells. Requirement for IL-1 and IL-6. J Immunol 1988, 141: 2907 3. van Snick, J et al; Interleukin-6: an overview. Annu Rev Immunol 1990, 8: 253 4. Heinrich, PC et al; Interleukin-6 and the acute phase response. Biochem J 1990, 265: 621 5. Starnes, HF Jr et al; Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol 1990, 145: 4185 6. Hirano, T et al; Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Int J Cell Cloning 1991, 9: 166 7. Hooghe-Peters, E et al; Interleukin-1, interleukin-6: messengers in the neuroendocrine immune system? Pathol Res Pract 1991, 187: 622